Answers are grounded in this paper and cite their sources.
Population pharmacokinetics analysis shows high variability of propofol in critically ill patients, implying ECMO does not affect its metabolism.
Our popPK analysis shows that propofol PK does not differ between critically ill patients with and without ECMO and confirms a high PK variability in this population.
No takes yet. Share an insight, caveat, or question.
Bertin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: